Hydroxyzine, a first-generation histamine H1 receptor antagonist used for the symptomatic control of chronic spontaneous urticaria (CSU), was suggested as an alternative treatment option for panic disorder [14]. The gene discussed is HRH1; the disease is panic disorder.